Successful treatment of persistent and severe SARS-CoV-2 infection in a high-risk chronic lymphocytic leukemia patient using Ronapreve™ antibodies.

Fernanda Braga Seganfredo Ana Raquel DiasPedro R SantosMarta RebeloCristina Joao Dina MendesEduarda Carmo

Published in: Clinical case reports (2022)

Patients with lymphoproliferative diseases are at an increased risk of an incomplete immune response following vaccination or SARS-CoV-2 infection and might develop persistent viral infection and severe COVID-19 disease. We present a case of successful treatment of persistent and mechanical-ventilation-requiring SARS-CoV-2 infection in a del17 + CLL patient using exogenous antibodies.

Keyphrases

chronic lymphocytic leukemia
mechanical ventilation
respiratory syndrome coronavirus
immune response
sars cov
coronavirus disease
case report
acute respiratory distress syndrome
intensive care unit
early onset
toll like receptor
dendritic cells